EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY

被引：0
|
作者：
Saliba, Faouzi [1 ]
De Simone, Paolo [2 ]
Nevens, Frederik [3 ]
De Carlis, Luciano [4 ]
Metselaar, Herold [5 ]
Beckebaum, Susanne [6 ]
Jonas, Sven [7 ]
Sudan, Debra [8 ]
Fischer, Lutz [9 ]
Fung, John J. [10 ]
Jiang, Hai [11 ]
Junge, Guido [12 ]
机构：
[1] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France
[2] Azienda Osped Univ Pisana, Pisa, Italy
[3] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[4] Osped Niguarda Ca Granda, Milan, Italy
[5] Univ Hosp Rotterdam, Erasmus MC, Rotterdam, Netherlands
[6] Univ Hosp Essen, Essen, Germany
[7] Univ Med Ctr Leipzig, Leipzig, Germany
[8] Duke Univ, Med Ctr, Durham, NC USA
[9] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[11] Novartis Pharmaceut, E Hanover, NJ USA
[12] Novartis Pharma AG, Basel, Switzerland
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1430A / 1431A
页数：2
相关论文
共 50 条
  • [21] Everolimus-Facilitated Reduction Of Tacrolimus Provides Comparable Efficacy And Superior Renal Function Versus Standard Tacrolimus In De Novo Liver Transplant Recipients: 24-Month Results Of A Randomized Trial
    Saliba, Faouzi
    De Simone, Paolo
    Nevens, Frederik
    De Carlis, Luciano
    Metselaar, Herold
    Beckebaum, Susanne
    Jonas, Sven
    Sudan, Debra
    Fischer, Lutz
    Fung, John J.
    Dong, Gaohong
    Lopez, Patricia M.
    Junge, Guido
    HEPATOLOGY, 2012, 56 (06) : 1519 - 1519
  • [22] Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials
    Lee, Sung-Gyu
    Jeng, Long-Bin
    Saliba, Faouzi
    Soin, Arvinder Singh
    Lee, Wei-Chen
    De Simone, Paolo
    Nevens, Frederik
    Suh, Kyung-Suk
    Fischer, Lutz
    Joo, Dong Jin
    Fung, John
    Joh, Jae-Won
    Kaido, Toshimi
    Grant, David
    Meier, Matthias
    Rauer, Barbara
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    TRANSPLANTATION, 2021, 105 (07) : 1564 - 1575
  • [23] Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Huang, M. A.
    Chapman, W. C.
    Foltys, D.
    Witte, S.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (11) : 3008 - 3020
  • [24] Efficacy and Safety of Everolimus with Reduced-Exposure Tacrolimus and Corticosteroid Withdrawal in De Novo Pediatric Renal Transplant Recipients: 12-Month Results from the CRADLE Study
    Ettenger, R.
    Tonshoff, B.
    Tedesco, H.
    Dello Strologo, L.
    Marks, S.
    Pape, L.
    Martzloff, E.
    Rauer, B.
    Ng, J.
    Lopez, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 407 - 408
  • [25] Everolimus facilitated reduction of tacrolimus in de novo liver transplant recipients (LTxR): 12-24 month data from North America
    Chapman, W. C.
    Brown, R. S., Jr.
    Sudan, D.
    Chavin, K. D.
    Koneru, B.
    Huang, M. A.
    Junge, G.
    Hexham, J. M.
    Dong, G.
    Wiland, A.
    Patel, D.
    Fung, J.
    PHARMACOTHERAPY, 2013, 33 (10): : E237 - E238
  • [26] Everolimus Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients: 12-24 Month Data from North America.
    Chapman, W.
    Brown, R., Jr.
    Sudan, D.
    Chavin, K.
    Koneru, B.
    Huang, M.
    Junge, G.
    Hexham, J.
    Dong, G.
    Wiland, A.
    Fung, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 506 - 507
  • [27] 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients
    Tedesco-Silva, Helio, Jr.
    Vitko, Stefan
    Pascual, Julio
    Eris, Josette
    Magee, John C.
    Whelchel, John
    Civati, Giovanni
    Campbell, Scott
    Alves-Filho, Gentil
    Bourbigot, Bernard
    Garcia, Valter Duro
    Leone, John
    Esmeraldo, Ronaldo
    Rigotti, Paolo
    Cambi, Vincenzo
    Haas, Tomas
    TRANSPLANT INTERNATIONAL, 2007, 20 (01) : 27 - 36
  • [28] HEPHAISTOS study: Early use of everolimus plus reduced tacrolimus in de novo liver transplant recipients achieves high efficacy and safety compared to standard tacrolimus.
    Schemmer, P.
    Nashan, B.
    Braun, F.
    Pascher, A.
    Klein, C. -G
    Neumann, U.
    Kroeger, I
    Wimmer, P.
    Schlitt, H. J.
    TRANSPLANTATION, 2019, 103 (08) : 298 - 298
  • [29] THE TRANSFORM STUDY: 12-MONTH EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITOR IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Pascual, Julio
    Berger, Stefan
    Witzke, Oliver
    Chadban, Steve
    Oppenheimer, Federico
    Oberbauer, Rainer
    Watarai, Yoshihiko
    Legendre, Christophe
    Luo, Wen-Lin
    Marti, Anamaria
    Bernhardt, Peter
    Tedesco, Helio
    TRANSPLANT INTERNATIONAL, 2017, 30 : 159 - 159
  • [30] Design and Baseline Data from Hephaistos Study Evaluating Efficacy and Safety of Early Initiation of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients
    Nashan, Bjorn
    Schemmer, Peter
    Braun, Felix
    Dworak, Markus
    Wimmer, Peter
    Schlitt, Hans
    TRANSPLANTATION, 2015, 99 : 214 - 215
12345